智飞生物(300122.SZ)：冻干水痘灭活疫苗获临床试验批准

Core Viewpoint - The company Zhifei Biological Products Co., Ltd. has received approval from the National Medical Products Administration for clinical trials of its lyophilized varicella inactivated vaccine, aimed at preventing chickenpox caused by varicella-zoster virus infection [1] Group 1 - The clinical trial approval is granted to the company's wholly-owned subsidiary, Anhui Zhifei Longkema Biological Pharmaceutical Co., Ltd. [1] - The vaccine is intended to address infections caused by the varicella-zoster virus, which leads to chickenpox [1]